0
Ironwood Pharmaceuticals, Inc. Banner Image

Ironwood Pharmaceuticals, Inc.

  • Ticker IRWD
    Exchange NASDAQ More
  • Industry Drugs - Generic More
  • Sector Healthcare More
Ironwood Pharmaceuticals, Inc. Logo Image
  • 201-500 Employees
  • Based in Cambridge, Massachusetts
Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name inMore the United States and Constella name in the European Union.
Ironwood Pharmaceuticals, Inc.

Most Recent Responsibility Report

Ironwood Pharmaceuticals, Inc.
MOST RECENT 2022 Environmental, Social and Governance Report
Our service enables potential investors to review the most recent and archived Ironwood Pharmaceuticals, Inc. Sustainability Report, Ironwood Pharmaceuticals, Inc. Corporate Social Responsibility Report, Ironwood Pharmaceuticals, Inc. CSR Report, Ironwood Pharmaceuticals, Inc. Corporate Responsibility, Ironwood Pharmaceuticals, Inc. CR Report, Ironwood Pharmaceuticals, Inc. Citizenship Report, Ironwood Pharmaceuticals, Inc. ESG Report, and Ironwood Pharmaceuticals, Inc. Environmental Report online.
Ironwood Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!